Please use this identifier to cite or link to this item:
https://doi.org/10.1080/17425255.2018.1541347
| Title: | CDK4-6 inhibitors in breast cancer: current status and future development | Authors: | Joan Choo Soo-Chin Lee |
Issue Date: | 3-Nov-2018 | Publisher: | Taylor & Francis | Citation: | Joan Choo, Soo-Chin Lee (2018-11-03). CDK4-6 inhibitors in breast cancer: current status and future development. Expert Opinion on Drug Metabolism & Toxicology 11 (14) : 1123-1138. ScholarBank@NUS Repository. https://doi.org/10.1080/17425255.2018.1541347 | Source Title: | Expert Opinion on Drug Metabolism & Toxicology | URI: | http://scholarbank.nus.edu.sg/handle/10635/149940 | ISSN: | 1742-5255 | DOI: | 10.1080/17425255.2018.1541347 |
| Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
| File | Description | Size | Format | Access Settings | Version | |
|---|---|---|---|---|---|---|
| 10.108017425255.2018.1541347.zip | 2 MB | ZIP | OPEN | None | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.